Go Back Menu
Close
Management
Working together
toward a common vision
View Full Bio 
Mr. Ramesh Juneja
Chairman & Whole-Time Director
Mr. Ramesh Juneja
Chairman & Whole-Time Director
Mr. Ramesh Juneja, a visionary leader with over 33 years of experience in the pharmaceutical industry. Under his forward-thinking leadership, Mankind Pharma transformed from a small venture into a billion-dollar generics giant, making affordable medicines accessible across India. He co-founded the company in 1995 with his brother, Rajeev Juneja, championing low-cost generics as a core ethos. His commitment to quality and transparency has earned him prestigious awards, including ‘Entrepreneur of the Year’ 2023 by Economic Times. Beyond business, he prioritizes ethical business practices and employee well-being, fostering a culture of integrity at Mankind Pharma. Mr. Juneja envisions a ‘Healthier Bharat’ in the future where every Indian has access to quality and affordable medication.
View Full Bio
Mr. PK Arora
Director - FHA
Mr. PK Arora
Director - FHA
Mr. Prem Kumar Arora, co-founded Mankind Pharma alongside Ramesh and Rajeev Juneja. He has been instrumental in shaping the company’s growth and strategic direction, helping Mankind Pharma emerge as the fourth-largest pharmaceutical company in India by domestic sales. Overseeing finance, HR, and operations, he ensures affordability, quality, and accessibility remain at the company’s core. His strategic vision has expanded Mankind Pharma’s reach to over 30+ countries. Beyond Mankind Pharma, he holds directorships in 15 companies across real estate, hospitality, and healthcare, including Pathkind Diagnostics. His leadership continues to drive Mankind Pharma’s mission of delivering cost-effective healthcare globally.
View Full Bio
Mr. Rajeev Juneja
Managing Director & Vice Chairman
Mr. Rajeev Juneja
Managing Director & Vice Chairman
Mr. Rajeev Juneja is a first-generation entrepreneur who co-founded Mankind Pharma in 1995 with his brother, Ramesh Juneja, after gaining deep market insights. His visionary leadership has positioned Mankind among India’s top pharmaceutical companies. Known for his innovative and customer-centric approach, he has driven Mankind Pharma’s expansion into OTC and super speciality segments while fostering a strong culture of teamwork and agility. A believer in continuous learning, he nurtures talent and champions ground-breaking ideas to ensure sustainable growth. His efforts have earned him accolades, including the “Entrepreneur of the Year” 2023 by Economic Times.
View Full Bio
Mr. Sheetal Arora
CEO & Whole-Time Director
Mr. Sheetal Arora
CEO & Whole-Time Director
Mr Sheetal Arora is a trailblazing leader driving the company’s operations, global expansion and innovation. With over 25 years of experience, he has played a pivotal role in launching specialty divisions and managing emerging markets. His expertise spans sales, marketing, and field force management across domestic and international markets. Under his leadership, Mankind Pharma has expanded into new divisions like Lifestar Pharma and Star Mankind. Mr. Arora also has diverse experience across ROW countries and emerging markets. One of his strongest assets is his ability to excel within diverse socio-cultural environments.
View Full Bio
Mr. Arjun Juneja
Chief Operating Officer
Mr. Arjun Juneja
Chief Operating Officer
Mr. Arjun Juneja has been instrumental in driving innovation, operational excellence, and global expansion at Mankind Pharma. Since joining in 2009, he has overseen R&D, manufacturing, supply chain, and IT, leading Mankind’s successful IPO in 2023. He spearheaded Mankind Pharma’s entry into the US market and secured USFDA approvals for regulated markets. Under his leadership, state-of-the-art R&D centers in Manesar were established, fostering pharmaceutical advancements. He also transformed Mankind Pharma from a family-run business into a professionally managed institution while overseeing strategic investments through the Mankind Family Office. Recognized among India’s top young business leaders, he serves as Chairman of FICCI’s Pharma Committee.
